{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:44Z","timestamp":1786119584112,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/jcp.0b013e3181faa668","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T00:56:09Z","timestamp":1288918569000},"page":"745-746","source":"Crossref","is-referenced-by-count":5,"title":["A Case of Catatonia Successfully Treated With Ziprasidone, in a Patient With DSM-IV Delusional Disorder"],"prefix":"10.1097","volume":"30","author":[{"given":"Elias K.","family":"Angelopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Corcondilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas T.","family":"Kollias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanellos T.","family":"Kioulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna-Despoina","family":"Bergiannaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia, I. Rating scale and standardized examination.","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"R2-23-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","article-title":"Catatonia II. Treatment with lorazepam and electroconvulsive therapy.","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"R3-23-20210128","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1176\/appi.ajp.160.7.1233","article-title":"Catatonia in psychiatric classification: a home of its own.","volume":"160","author":"Taylor","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R4-23-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/pb.26.10.393","article-title":"Catatonia and NMS.","volume":"26","author":"Fink","year":"2002","journal-title":"Psychiatr Bull"},{"key":"R5-23-20210128","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.62.4.404","article-title":"Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.","volume":"62","author":"Northoff","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-23-20210128","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1176\/appi.ajp.162.3.626","article-title":"Memantine and catatonic schizophrenia.","volume":"162","author":"Thomas","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"suppl 4","key":"R7-23-20210128","first-page":"12","article-title":"Movement disorders associated with atypical antipsychotic drugs.","volume":"63","author":"Caroff","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R8-23-20210128","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1017\/S0033291705005453","article-title":"Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales.","volume":"35","author":"Chalasani","year":"2005","journal-title":"Psychol Med"},{"key":"R10-23-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002130050904","article-title":"Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.","volume":"142","author":"Ungvari","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"R12-23-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1399-5618.2003.00092.x","article-title":"Use of ziprasidone to treat bipolar-associated catatonia.","volume":"6","author":"Levy","year":"2004","journal-title":"Bipolar Disord"},{"key":"R13-23-20210128","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2009.12.023","article-title":"DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication.","volume":"118","author":"Peralta","year":"2010","journal-title":"Schizophr Res"},{"key":"R14-23-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1092852900013365","article-title":"The universal field hypothesis of catatonia and neuroleptic malignant syndrome.","volume":"5","author":"Carroll","year":"2000","journal-title":"CNS Spectr"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e3181faa668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:46Z","timestamp":1786041526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201012000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181faa668","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}